The largest database of trusted experimental protocols

Cobas mira plus autoanalyzer

Manufactured by Roche
Sourced in Spain, Switzerland

The Cobas Mira Plus Autoanalyzer is a clinical chemistry analyzer designed for automated analysis of various biochemical parameters in clinical samples. It is capable of performing a wide range of tests, including measurement of enzymes, substrates, and other analytes. The Cobas Mira Plus is intended for use in clinical laboratories and provides automated sample handling, reagent management, and data processing capabilities.

Automatically generated - may contain errors

12 protocols using cobas mira plus autoanalyzer

1

Quantification of Protein and LDH in BALF

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total protein and albumin were determined in the first acellular lavage fluid using a dye-based assay kit (Roche Diagnostics, Indianapolis, IN) performed on a COBAS MIRA Plus autoanalyzer (Roche Diagnostics) according to the manufacturer’s instructions; quantitation employed a protein standard solution (Sigma-Aldrich, St. Louis, MO). Lactate dehydrogenase (LDH) activity was determined in the first acellular lavage fluid using an enzyme-activity-based assay kit performed on the COBAS MIRA Plus autoanalyzer (Roche Diagnostics) according to the manufacturer’s instructions. Protein measurement data are presented in Supplemental File 3.
+ Open protocol
+ Expand
2

Lipid Profile Measurement in Humans and Animals

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples (drawn from LKDs after an overnight fast) were obtained immediately before surgery, prior to anesthesia induction. Cholesterol was determined using an enzymatic method (Hoffmann-LaRoche, Basel, Switzerland). The high-sensitivity C-reactive protein (hs-CRP) was measured using an immunoturbidimetric assay with a Cobas Mira Plus autoanalyzer (Hoffmann-LaRoche, Basel, Switzerland). Subjects were arbitrarily considered hypercholesteremic if their fasting plasma cholesterol levels exceeded 5 mmol/L or if they were on a statin treatment. No other hypolipidaemic treatment was used by the subjects. The high-density lipoprotein (HDL) cholesterol concentration was measured after the phosphotungstate precipitation of the apolipoprotein-B-containing lipoproteins and LDL cholesterol levels were calculated.
In our animal experiment, cholesterol was measured in the blood plasma and in the lipoprotein particles (very low-density lipoprotein (VLDL) d < 1.006 g/mL, intermediate-density lipoprotein (IDL) d = 1.006–1.019 g/mL, LDL d = 1.019–1.063 g/mL, and HDL d = 1.063–1.210 g/mL) separated by sequential ultracentrifugation.
+ Open protocol
+ Expand
3

Measuring Lung Cytotoxicity in BAL Supernatant

Check if the same lab product or an alternative is used in the 5 most similar protocols
The first BAL supernatant lavage fraction was used to measure LDH activity, indicative of lung cytotoxicity. LDH activity was analyzed using a COBAS MIRA Plus auto-analyzer (Roche Diagnostic Systems; Montclair, NJ) which measured the oxidation of lactate to pyruvate coupled with the formation of NADH at 340 nm.
For analysis of the BAL cells, the supernatant from the second lavage fraction was discarded and the cell pellets of both fractions were combined. The final cell pellet suspended in 800 μl of PBS was used for cell counts and differential staining. Total cell numbers were determined using a hemocytometer. For cell differentials, cells were plated onto glass slides using a Cytospin 3 centrifuge (Shandon Life Sciences International; Cheshire, England) set at 800 rpm for 5 minutes. Slides were stained with Hema 3 Fixative and Solutions (Fisher Scientific; Pittsburgh, PA) then coverslipped. A minimum of 300 cells/slide, consisting of macrophages, lymphocytes, and polymorphonuclear leukocytes were identified using light microscopy.
+ Open protocol
+ Expand
4

Fasting Blood Lipid Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples were obtained after a 10 h fast. The serum was immediately frozen at −120 °C in liquid nitrogen for transport and stored at −80 °C for final conservation. Total cholesterol and high-density lipoprotein (HDL) cholesterol were analyzed by standardized enzymatic methods (Roche Diagnostic, Basel, Switzerland) adapted to a Cobas Mira Plus autoanalyzer (Hoffmann-La Roche, Basel, Switzerland). Smoking was self-reported by standardized questions.
+ Open protocol
+ Expand
5

Comprehensive Metabolic Profile in Wistar Rats

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDLc), non-high-density lipoprotein cholesterol (non-HDLc), alanine aminotransferase (ALT), aspartate aminotransferase (AST) and glucose were measured in the Wistar rat plasma by standardized methods using the Cobas Mira Plus autoanalyzer (Roche Diagnostics, Spain). Insulin was measured by Mercodia Rat Insulin Enzyme-linked Immuno Sorbent Assay (ELISA; reference 10-1250-10) from AD Bioinstruments S.L. (Barcelona, Spain).
TC, TG, HDLc, non-HDLc, and Glucose are expressed as mg/dL, insulin is expressed as µg/L, and ALT and AST are expressed as U/L. Non-HDLc was calculated by subtracting the HDLc value from the TC value, for each case.
+ Open protocol
+ Expand
6

Carotid Intima-Media Thickness and Cardiometabolic Risk

Check if the same lab product or an alternative is used in the 5 most similar protocols
Complete anamnesis and anthropometric data, including sex, age, clinical history, and medication, were entered into our database after physical examination. Weight and height values were used to determine the BMI. The carotid intima-media thickness (cIMT) of the right and left common carotid arteries was assessed using a MyLab 60-X Vision sonographer (Esaote, Genova, Italy), and the mean cIMT was determined by averaging the readings from the two carotid arteries. cIMT more than 1.5 mm or protrusions into the lumen that were 50% thicker than the cIMT around them were classified as plaques. Blood samples taken from each participant were prepared for storage at −80 °C in our center’s BioBank prior to usage. Standard biochemical parameters including lipids, apolipoproteins, glucose, and high-sensitivity C-reactive protein (hsCRP) were measured utilizing colorimetric, enzymatic, and immunoturbidimetric assays (Spinreact SA, Spain; Horiba SA, Spain), which were adapted for the Cobas Mira Plus Autoanalyzer (Roche Diagnostics, Spain). Plasma levels of insulin were determined with enzyme-linked immunosorbent assays (ELISAs) following the corresponding manufacturer’s instructions (Mercodia AB, Uppsala, Sweden). Insulin resistance was calculated using the homeostasis model assessment of insulin resistance (HOMA-IR): [fasting insulin (µU/mL) × fasting glucose (mg/dL)/405] [23 (link)].
+ Open protocol
+ Expand
7

Comprehensive Cardiometabolic Biomarker Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Anamnesis and anthropometric data, including sex, age, clinical history and medication, were recorded and included in the research institute database. BMI was calculated from weight and height measurements (kg/m2). Standard biochemical parameters, including lipids, apolipoproteins, Lp(a), blood glucose and hsCRP, were measured using colorimetric, enzymatic and immunoturbidimetric assays (Spinreact, Girona, Spain; Horiba, Kioto, Japan), which were adapted for automation by clinical chemistry Cobas Mira Plus Autoanalyzer (Roche Diagnostics, Basilea, France).
The standard LDL cholesterol concentration was calculated using the Friedewald formula [62 ], and the remnant cholesterol concentration was calculated by subtracting LDL and HDL cholesterol from total cholesterol.
Circulating PCSK9 was measured by enzyme-linked immunosorbent assay (ELISA) kits (R&D Systems, Minneapolis, MN, USA) following the reagent manufacturer’s instructions.
+ Open protocol
+ Expand
8

Blood Lipid Profiling Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fasting venous blood samples were collected in EDTA tubes and centrifuged immediately for 15 min at 1500× g and 4 °C to obtain plasma. The samples were then divided into aliquots and stored at −80 °C until analysis.
Standard laboratory methods were used to quantify the total cholesterol, triglycerides and HDL cholesterol contents. LDL cholesterol values were calculated using the Friedewald formula [21 (link)]. Apolipoproteins were quantified using an immunoturbidimetric assay with specific antibodies against apolipoprotein A1 (Apo A1), apolipoprotein B100 (Apo B100) and apolipoprotein CIII (Apo CIII). These analyses were adapted for the Cobas-Mira-Plus autoanalyzer (Roche Diagnosis, Barcelona, Spain).
+ Open protocol
+ Expand
9

Metabolic Biomarkers Analysis in Fasted Subjects

Check if the same lab product or an alternative is used in the 5 most similar protocols
Animals were fasted for 4h, and a blood sample was collected. Plasma samples were analyzed for triglycerides, total cholesterol, HDL cholesterol (HDLc), glucose (Spinreact; Barcelona, Spain), and non-esterified fatty acids (NEFAs) (Wako; Osaka, Japan) via standardized colorimetric methods adapted to the Cobas Mira Plus Autoanalyzer (Roche Diagnostics, Barcelona, Spain). The low-density lipoprotein cholesterol (LDLc) concentration was calculated using the Friedewäld formula, and the concentration of VLDLc was determined by the formula total cholesterol—(HDLc + LDLc). Plasma levels of insulin, resistin, leptin, and adiponectin were determined by commercial ELISA Kits (Milliplex®, Millipore; Billerica, MA, USA). The homeostatic model assessment (HOMA) index was calculated as previously described [23 (link),63 (link)].
+ Open protocol
+ Expand
10

Lipid Profile and CRP Measurement

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total cholesterol, triglyceride, and HDL-cholesterol fractions were determined from fasting blood samples obtained immediately before surgery (prior to anesthesia) using an enzymatic method (Hoffmann-LaRoche, Basel, Switzerland). C-reactive protein (hsCRP) was measured by immunoturbidimetric assay using a Cobas Mira Plus autoanalyzer (Hoffmann-LaRoche, Basel, Switzerland).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!